Assignee
KALA PHARMACEUTICALS INC
US·54 granted patents·13 pending applications·212 citations·filing 2005–2022
Top patents by PatentIndex Score
67 records- 0198US9056057B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2013·Granted Jun 16, 2015·56 cites·28 claims
- 0298US8354476B2Functionalized poly(ether-anhydride) block copolymersKALA PHARMACEUTICALS INC·Filed 2005·Granted Jan 15, 2013·54 cites·26 claims
- 0395US11318088B2Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2020·Granted May 3, 2022·3 cites·22 claims
- 0495US9458169B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Oct 4, 2016·22 cites·23 claims
- 0594US9790232B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2015·Granted Oct 17, 2017·12 cites·20 claims
- 0693US9353122B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·14 cites·50 claims
- 0791US10160765B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Dec 25, 2018·7 cites·15 claims
- 0890US10618906B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Apr 14, 2020·2 cites·14 claims
- 0989US9393213B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2015·Granted Jul 19, 2016·2 cites·28 claims
- 1087US9877970B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2016·Granted Jan 30, 2018·4 cites·26 claims
- 1187US9580421B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2015·Granted Feb 28, 2017·4 cites·20 claims
- 1286US10398703B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Sep 3, 2019·3 cites·26 claims
- 1385US10758539B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Sep 1, 2020·1 cites·23 claims
- 1485US10336767B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Jul 2, 2019·3 cites·8 claims
- 1584US11104685B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2020·Granted Aug 31, 2021·1 cites·6 claims
- 1684US10688041B2Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2013·Granted Jun 23, 2020·2 cites·33 claims
- 1783US10626121B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Apr 21, 2020·1 cites·8 claims
- 1883US9861634B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2016·Granted Jan 9, 2018·2 cites·21 claims
- 1983US9532955B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2016·Granted Jan 3, 2017·1 cites·20 claims
- 2083US9353123B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·3 cites·35 claims
- 2182US9827248B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2016·Granted Nov 28, 2017·2 cites·21 claims
- 2282US9688688B2Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Jun 27, 2017·2 cites·16 claims
- 2382US9212145B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Dec 15, 2015·3 cites·80 claims
- 2481US10392388B2Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 27, 2019·2 cites·38 claims
- 2581US2023116686A1Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2680US9988386B2Compounds for treatment of diseases of abnormal angiogenesis or aberrant growth factors and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Jun 5, 2018·3 cites·23 claims
- 2779US10059693B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 28, 2018·1 cites·29 claims
- 2879US10059692B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 28, 2018·1 cites·31 claims
- 2978US9802922B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Oct 31, 2017·1 cites·12 claims
- 3076US11713323B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Granted Aug 1, 2023·0 cites·10 claims
- 3175US2021355136A1Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3274US11369611B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·0 cites·9 claims
- 3374US11352343B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2020·Granted Jun 7, 2022·0 cites·21 claims
- 3474US11091487B2Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Aug 17, 2021·0 cites·22 claims
- 3574US2022106326A1Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3674US2021393641A1Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3773US10975090B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2020·Granted Apr 13, 2021·0 cites·12 claims
- 3872US10966987B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Apr 6, 2021·0 cites·21 claims
- 3972US2021380588A1Novel Compounds and Uses ThereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4071US10723719B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Jul 28, 2020·0 cites·20 claims
- 4171US2021332048A1Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4270US11021487B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Jun 1, 2021·0 cites·17 claims
- 4369US10954244B2Compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Mar 23, 2021·0 cites·20 claims
- 4468US10766907B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Sep 8, 2020·0 cites·19 claims
- 4568US10329280B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Jun 25, 2019·0 cites·20 claims
- 4668US10316022B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·0 cites·18 claims
- 4768US10285991B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted May 14, 2019·0 cites·26 claims
- 4868US10253036B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Apr 9, 2019·0 cites·7 claims
- 4968US2021261562A1Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 5067US10875857B21-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Dec 29, 2020·0 cites·15 claims
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when KALA PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →